IMpassion130研究: 阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌的疗效分析

    IMpassion130: The Efficacy of Atezolizumab Plus Nab-Paclitaxel Treatment in Comparison With Nab-Paclitaxel Alone as First-Line Treatment of Advanced Triple-Negative Breast Cancer

    /

    返回文章
    返回